[Influence of Shenlian decoction on early lesion of atherosclerosis in rats]

Zhongguo Zhong Yao Za Zhi. 2011 Jan;36(1):66-71.
[Article in Chinese]

Abstract

Objective: To establish the atherosclerosis models (AS) in rats and observe the change process of AS and Shenlian decoction's pharmacological effect.

Method: Two hundreds and forty rats were randomly divided into blank control group, model group, positive medicine group, the high-dose, middle dose and low-dose Shenlian decoction groups. Vascular pathological changes were observed by the methods of HE stain. The levels of TC, TG, LDL-C, HDL-C, NO in serum were determined respectively by enzyme colorimetric, clear and nitrate reductase methods. ET, TXB2, 6-keto-PGF1 alpha, TNF-alpha, IL-6 and IL-8 levels in serum were detected by radioimminoassay.

Result: Compared with the model group, vascular lesion of different doses of Shenlian decoction groups were significantly improved, the TG, NO, TXB2 levels in serum were significantly lower (P < 0.05), while high-dose Shenlian decoction can significantly reduce TNF-alpha, IL-6, IL-8 levels in serum (P < 0.05).

Conclusion: Shenlian decoction can inhibit the formation and development of AS by regulating blood lipids, improving endothelial function and reducing inflammatory factors release.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Atherosclerosis / blood
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / pathology*
  • Atherosclerosis / prevention & control
  • Disease Models, Animal
  • Drugs, Chinese Herbal / administration & dosage*
  • Humans
  • Interleukin-6 / blood
  • Male
  • Protective Agents / administration & dosage*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Drugs, Chinese Herbal
  • Interleukin-6
  • Protective Agents
  • Tumor Necrosis Factor-alpha